BofA Securities analyst Tim Anderson reiterated a Neutral rating and $207.00 price target on Biogen (NASDAQ: BIIB)The analyst commented, "Biogen ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE